Business ❯ Pharmaceutical Industry ❯ Pricing Strategies

Market Access

Consumer Impact Insurance Coverage Eli Lilly Negotiations Innovation Costs Branded Medicines Regulatory Challenges Novo Nordisk and Eli Lilly Consumer Discounts Novo Nordisk Mounjaro Consumer Sales International Pricing Cost Management

UK–US Pharma Deal Could Force NHS to Divert £45bn and Cause 229,000 Excess Deaths

The BMJ modelling warns a withheld DHSC impact assessment leaves open the prospect that NHS budgets will have to cover much higher drug bills

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

Bristol Myers Sets U.K. Price for New Schizophrenia Drug Equal to U.S., Threatens to Pull Product